Copyright Reports & Markets. All rights reserved.

Global Follicle Stimulating Hormone (FSH) Injections Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 by Injection Type
    • 1.3.3 by Source of Ingredients
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 IVF and Embryo Transfer
    • 1.4.3 Infertility Treatment
  • 1.5 Global Follicle Stimulating Hormone (FSH) Injections Market Size & Forecast
    • 1.5.1 Global Follicle Stimulating Hormone (FSH) Injections Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity (2021-2032)
    • 1.5.3 Global Follicle Stimulating Hormone (FSH) Injections Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Gonal-F (Merck)
    • 2.1.1 Gonal-F (Merck) Details
    • 2.1.2 Gonal-F (Merck) Major Business
    • 2.1.3 Gonal-F (Merck) Follicle Stimulating Hormone (FSH) Injections Product and Services
    • 2.1.4 Gonal-F (Merck) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Gonal-F (Merck) Recent Developments/Updates
  • 2.2 Follistim (Organon)
    • 2.2.1 Follistim (Organon) Details
    • 2.2.2 Follistim (Organon) Major Business
    • 2.2.3 Follistim (Organon) Follicle Stimulating Hormone (FSH) Injections Product and Services
    • 2.2.4 Follistim (Organon) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Follistim (Organon) Recent Developments/Updates
  • 2.3 Bravelle (Ferring)
    • 2.3.1 Bravelle (Ferring) Details
    • 2.3.2 Bravelle (Ferring) Major Business
    • 2.3.3 Bravelle (Ferring) Follicle Stimulating Hormone (FSH) Injections Product and Services
    • 2.3.4 Bravelle (Ferring) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Bravelle (Ferring) Recent Developments/Updates
  • 2.4 Menopur (Ferring)
    • 2.4.1 Menopur (Ferring) Details
    • 2.4.2 Menopur (Ferring) Major Business
    • 2.4.3 Menopur (Ferring) Follicle Stimulating Hormone (FSH) Injections Product and Services
    • 2.4.4 Menopur (Ferring) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Menopur (Ferring) Recent Developments/Updates
  • 2.5 Fostimon (IBSA)
    • 2.5.1 Fostimon (IBSA) Details
    • 2.5.2 Fostimon (IBSA) Major Business
    • 2.5.3 Fostimon (IBSA) Follicle Stimulating Hormone (FSH) Injections Product and Services
    • 2.5.4 Fostimon (IBSA) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Fostimon (IBSA) Recent Developments/Updates
  • 2.6 Puregon (Organon)
    • 2.6.1 Puregon (Organon) Details
    • 2.6.2 Puregon (Organon) Major Business
    • 2.6.3 Puregon (Organon) Follicle Stimulating Hormone (FSH) Injections Product and Services
    • 2.6.4 Puregon (Organon) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Puregon (Organon) Recent Developments/Updates
  • 2.7 BEMFOLA (Gedeon Richter)
    • 2.7.1 BEMFOLA (Gedeon Richter) Details
    • 2.7.2 BEMFOLA (Gedeon Richter) Major Business
    • 2.7.3 BEMFOLA (Gedeon Richter) Follicle Stimulating Hormone (FSH) Injections Product and Services
    • 2.7.4 BEMFOLA (Gedeon Richter) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
  • 2.8 Follitrope (LG Chem)
    • 2.8.1 Follitrope (LG Chem) Details
    • 2.8.2 Follitrope (LG Chem) Major Business
    • 2.8.3 Follitrope (LG Chem) Follicle Stimulating Hormone (FSH) Injections Product and Services
    • 2.8.4 Follitrope (LG Chem) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Follitrope (LG Chem) Recent Developments/Updates
  • 2.9 Livzon
    • 2.9.1 Livzon Details
    • 2.9.2 Livzon Major Business
    • 2.9.3 Livzon Follicle Stimulating Hormone (FSH) Injections Product and Services
    • 2.9.4 Livzon Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Livzon Recent Developments/Updates
  • 2.10 GenSci
    • 2.10.1 GenSci Details
    • 2.10.2 GenSci Major Business
    • 2.10.3 GenSci Follicle Stimulating Hormone (FSH) Injections Product and Services
    • 2.10.4 GenSci Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 GenSci Recent Developments/Updates

3 Competitive Environment: Follicle Stimulating Hormone (FSH) Injections by Manufacturer

  • 3.1 Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Follicle Stimulating Hormone (FSH) Injections Revenue by Manufacturer (2021-2026)
  • 3.3 Global Follicle Stimulating Hormone (FSH) Injections Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Follicle Stimulating Hormone (FSH) Injections by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Follicle Stimulating Hormone (FSH) Injections Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Follicle Stimulating Hormone (FSH) Injections Manufacturer Market Share in 2025
  • 3.5 Follicle Stimulating Hormone (FSH) Injections Market: Overall Company Footprint Analysis
    • 3.5.1 Follicle Stimulating Hormone (FSH) Injections Market: Region Footprint
    • 3.5.2 Follicle Stimulating Hormone (FSH) Injections Market: Company Product Type Footprint
    • 3.5.3 Follicle Stimulating Hormone (FSH) Injections Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Follicle Stimulating Hormone (FSH) Injections Market Size by Region
    • 4.1.1 Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Region (2021-2032)
    • 4.1.3 Global Follicle Stimulating Hormone (FSH) Injections Average Price by Region (2021-2032)
  • 4.2 North America Follicle Stimulating Hormone (FSH) Injections Consumption Value (2021-2032)
  • 4.3 Europe Follicle Stimulating Hormone (FSH) Injections Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Consumption Value (2021-2032)
  • 4.5 South America Follicle Stimulating Hormone (FSH) Injections Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2021-2032)
  • 5.2 Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Type (2021-2032)
  • 5.3 Global Follicle Stimulating Hormone (FSH) Injections Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2021-2032)
  • 6.2 Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Application (2021-2032)
  • 6.3 Global Follicle Stimulating Hormone (FSH) Injections Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2021-2032)
  • 7.2 North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2021-2032)
  • 7.3 North America Follicle Stimulating Hormone (FSH) Injections Market Size by Country
    • 7.3.1 North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2021-2032)
  • 8.2 Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2021-2032)
  • 8.3 Europe Follicle Stimulating Hormone (FSH) Injections Market Size by Country
    • 8.3.1 Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Market Size by Region
    • 9.3.1 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2021-2032)
  • 10.2 South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2021-2032)
  • 10.3 South America Follicle Stimulating Hormone (FSH) Injections Market Size by Country
    • 10.3.1 South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Market Size by Country
    • 11.3.1 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Follicle Stimulating Hormone (FSH) Injections Market Drivers
  • 12.2 Follicle Stimulating Hormone (FSH) Injections Market Restraints
  • 12.3 Follicle Stimulating Hormone (FSH) Injections Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Follicle Stimulating Hormone (FSH) Injections and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Follicle Stimulating Hormone (FSH) Injections
  • 13.3 Follicle Stimulating Hormone (FSH) Injections Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Follicle Stimulating Hormone (FSH) Injections Typical Distributors
  • 14.3 Follicle Stimulating Hormone (FSH) Injections Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Follicle Stimulating Hormone (FSH) Injections market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
    Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
    The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
    This report is a detailed and comprehensive analysis for global Follicle Stimulating Hormone (FSH) Injections market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Follicle Stimulating Hormone (FSH) Injections market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Follicle Stimulating Hormone (FSH) Injections market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Follicle Stimulating Hormone (FSH) Injections market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Follicle Stimulating Hormone (FSH) Injections market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Follicle Stimulating Hormone (FSH) Injections
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Follicle Stimulating Hormone (FSH) Injections market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gonal-F (Merck), Follistim (Organon), Bravelle (Ferring), Menopur (Ferring), Fostimon (IBSA), Puregon (Organon), BEMFOLA (Gedeon Richter), Follitrope (LG Chem), Livzon, GenSci, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Follicle Stimulating Hormone (FSH) Injections market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    by Injection Type
    by Source of Ingredients
    Market segment by Application
    IVF and Embryo Transfer
    Infertility Treatment
    Major players covered
    Gonal-F (Merck)
    Follistim (Organon)
    Bravelle (Ferring)
    Menopur (Ferring)
    Fostimon (IBSA)
    Puregon (Organon)
    BEMFOLA (Gedeon Richter)
    Follitrope (LG Chem)
    Livzon
    GenSci
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Follicle Stimulating Hormone (FSH) Injections product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Follicle Stimulating Hormone (FSH) Injections, with price, sales quantity, revenue, and global market share of Follicle Stimulating Hormone (FSH) Injections from 2021 to 2026.
    Chapter 3, the Follicle Stimulating Hormone (FSH) Injections competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Follicle Stimulating Hormone (FSH) Injections breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Follicle Stimulating Hormone (FSH) Injections market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Follicle Stimulating Hormone (FSH) Injections.
    Chapter 14 and 15, to describe Follicle Stimulating Hormone (FSH) Injections sales channel, distributors, customers, research findings and conclusion.

    Buy now